Humana shares are trading lower by 3.7% during Thursday's session. Shares are lower following UnitedHealth Group's earnings report, reflecting concerns about potential impacts on peers.

The Biden administration’s final regulation affecting the Medicare Advantage industry would come with a much lighter touch than the past two years.

Humana (HUM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Joanna Gajuk from Bank of

Higher medical expenses combined with stricter government payment policies have pressured UnitedHealth's earnings for more than a year.

Health insurance companies gained today with shares of Humana Inc. ( NYSE:HUM ), UnitedHealth Group ( NYSE:UNH) and CVS Health ( NYSE:CVS) are on the market movers list among top gainers. Government proposal that potentially raised payments for Medicare Advantage plans in 2026 was said to be the main reason for the increase.

Major healthcare plan provider UnitedHealth Group Incorporated UNH reported strong fourth-quarter earnings last week, primarily driven by growth in domestic commercial membership and Medicare Advantage.

Shares of health insurance companies are trading higher after The Centers for Medicare and Medicaid Services proposed a rise to Medicare Advantage payments.

CVS Health (NYSE:CVS), Humana (NYSE:HUM), Molina Healthcare (NYSE:MOH), and UnitedHealth Group (NYSE:UNH) saw an upswing following Elevance Health's latest quarterly results. Elevance Health, formerly known as Anthem,

UnitedHealth Group Inc. shares fell after elevated medical costs persisted in the fourth quarter and revenue missed estimates.Most Read from BloombergThese Homes Withstood the LA Fires. Architects Explain WhyChicago Agency Pitches $1.

A 145,000-square-foot office building in Ashwaubenon, home for more than two decades to an insurance company, will soon be redeveloped into space for a cafe, pickleball courts and several more businesses.

Additionally, the persistent shortage of medical personnel across the United States remains a significant challenge. Despite these hurdles, companies like UnitedHealth Group Inc., Humana Inc. and Centene Corp. appear well-placed to counter industry headwinds.